ISHARES GOLD TRUST GENOMICS IMMUNOLOGY AND HEALTHCARE ETF IDNA 深 沪
等待开盘 06-03 09:30:00 美东时间
28.68
-0.640
-2.18%
华盛通- 最 高29.00
- 今 开29.00
- 成交量 6.95万股
- 最 低 28.602
- 昨 收 29.32
- 总市值 1.56亿
- 52周最高 31.41
- 市盈率 静 --
- 换手率 1.28%
- 52周最低 19.9945
- 委 比 -50.00%
- 总股本 545.00万
- 历史最高 54.3869
- 量 比 2.07
- 振 幅 1.36%
- 历史最低 16.6299
- 每 手 1
- 风险率 3.45%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多JPMorgan analyst sees opportunities in healthcare and financials
Monica DiCenso, head of global investment opportunities at JPMorgan Private Bank, sees the recent market rally as an opportunity for investors to reposition portfolios toward financial (XLF) and healt...
04-15 22:44
Moderna’s rally ripples through biotech and health care ETFs
Shares of Moderna (MRNA) have surged sharply this week, drawing renewed attention to exchange traded funds with significant exposure to the U.S. pharmaceutical and biotechnology company. The stock cli...
01-23 00:12
BRIEF-Western Alliance Appoints Vishal Idnani As CFO
July 17 (Reuters) - Western Alliance Bancorp WAL.N: WESTERN ALLIANCE BANCORPORATION - APPOINTS VISHAL IDNANI AS CFO EFFECTIVE JAN 2, 2026 - SEC FILING WESTERN ALLIANCE BANCORPORATION - DALE GIBBONS TO...
2025-07-18 06:27
BRIEF-Thames Water Selects KKR As Preferred Partner In Equity Process
March 31 (Reuters) - Thames Water Utilities Finance PLC [RIC:RIC:IDNA.UL]: THAMES WTR UTIL. LTD - EQUITY RAISE UPDATE THAMES WATER UTILITIES LTD: SELECTING KKR TO ENTER PHASE 2 DILIGENCE STAGE OF EQUI...
2025-03-31 14:32
